Abstract

Study findings in the 1990s showed encouraging survival benefits in patients with early-stage non–small-cell lung cancer (NSCLC) who were treated with

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call